Cargando…
Shortened Palliative Radiotherapy Results in a Lower Rate of Treatment During the Last Month of Life
Introduction Palliative radiotherapy (PRT) during the last month of life (PRT30) should be avoided because relevant clinical benefits are unlikely to occur. While traditional short-course fractionation regimens are suitable for most patients, a minority may derive gains from higher doses of PRT. Com...
Autores principales: | Nieder, Carsten, Haukland, Ellinor C, Mannsåker, Bård |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881233/ https://www.ncbi.nlm.nih.gov/pubmed/35233303 http://dx.doi.org/10.7759/cureus.21617 |
Ejemplares similares
-
Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022) -
Palliative appropriateness criteria: external validation of a new method to evaluate the suitability of palliative radiotherapy fractionation
por: Nieder, Carsten, et al.
Publicado: (2023) -
Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019) -
Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017) -
The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017)